Handling stress may confound murine gut microbiota studies by Allen-Blevins, Cary R. (Author) et al.
Submitted 7 September 2016
Accepted 7 December 2016
Published 11 January 2017
Corresponding author
David A. Sela, davidsela@umass.edu
Academic editor
Yeong Yeh Lee
Additional Information and
Declarations can be found on
page 15
DOI 10.7717/peerj.2876
Copyright
2017 Allen-Blevins et al.
Distributed under
Creative Commons CC-BY 4.0
OPEN ACCESS
Handling stress may confound murine
gut microbiota studies
Cary R. Allen-Blevins1, Xiaomeng You2, Katie Hinde3,4 and David A. Sela2,5,6
1Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, United States
2Department of Food Science, University of Massachusetts, Amherst, MA, United States
3Center for Evolution and Medicine, Arizona State University, Tempe, AZ, United States
4 School of Human Evolution and Social Change, Arizona State University, Tempe, AZ, United States
5Department of Microbiology, University of Massachusetts, Amherst, MA, United States
6Center for Microbiome Research, University of Massachusetts Medical School, Worcester, MA,
United States
ABSTRACT
Background. Accumulating evidence indicates interactions between human milk
composition, particularly sugars (human milk oligosaccharides or HMO), the gut
microbiota of human infants, and behavioral effects. Some HMO secreted in human
milk are unable to be endogenously digested by the human infant but are able to be
metabolized by certain species of gut microbiota, including Bifidobacterium longum
subsp. infantis (B. infantis), a species sensitive to host stress (Bailey & Coe, 2004). Expo-
sure to gut bacteria like B. infantis during critical neurodevelopment windows in early
life appears to have behavioral consequences; however, environmental, physical, and
social stress during this period can also have behavioral and microbial consequences.
While rodent models are a useful method for determining causal relationships between
HMO, gut microbiota, and behavior, murine studies of gut microbiota usually employ
oral gavage, a technique stressful to the mouse. Our aim was to develop a less-invasive
technique for HMO administration to remove the potential confound of gavage stress.
Under the hypothesis that stress affects gut microbiota, particularly B. infantis, we
predicted the pups receiving a prebiotic solution in a less-invasive manner would have
the highest amount of Bifidobacteria in their gut.
Methods. This study was designed to test two methods, active and passive, of
solution administration to mice and the effects on their gut microbiome. Neonatal
C57BL/6J mice housed in a specific-pathogen free facility received increasing doses
of fructooligosaccharide (FOS) solution or deionized, distilled water. Gastrointestinal
(GI) tracts were collected from five dams, six sires, and 41 pups over four time points.
Seven fecal pellets from unhandled pups and two pellets from unhandled dams were
also collected. Qualitative real-time polymerase chain reaction (qRT-PCR) was used to
quantify and compare the amount of Bifidobacterium, Bacteroides, Bacteroidetes, and
Firmicutes.
Results. Our results demonstrate a significant difference between the amount of
Firmicutes in pups receiving water passively and those receiving FOS actively (p-value
= 0.009). Additionally, we found significant differences between the fecal microbiota
from handled and non-handled mouse pups.
Discussion. From our results, we conclude even handling pups for experimental
purposes, without gavage, may induce enough stress to alter the murine gut microbiota
profile. We suggest further studies to examine potential stress effects on gut microbiota
How to cite this article Allen-Blevins et al. (2017), Handling stress may confound murine gut microbiota studies. PeerJ 5:e2876; DOI
10.7717/peerj.2876
caused by experimental techniques. Stress from experimental techniques may need to
be accounted for in future gut microbiota studies.
Subjects Food Science and Technology, Microbiology, Gastroenterology and Hepatology,
Nutrition, Pediatrics
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INTRODUCTION
The gut microbiota has major physiological and potentially biopsychological implications
for human health (Lyte, 2010; Walter & Ley, 2011; Oh et al., 2010; Allen-Blevins, Sela &
Hinde, 2015). The collection of hundreds of bacterial species in the human gut exerts
strong influences on immune function, nutrition, and neurodevelopment through
maintaining gut barrier function, fermenting dietary fiber to short-chain fatty acids,
and producing neurotransmitters (Dinan et al., 2015;Grenham et al., 2011). Processes such
as programming the immune system likely begin with microbial exposure at birth and
perturbations in the gut microbiota early in development have been implicated in chronic
disease, including psychological conditions (Bäckhed et al., 2015; Douglas-Escobar, Elliott
& Neu, 2013; Rook, Lowry & Raison, 2013).
Recent research in mice suggests early gut microbiota affects neurodevelopment and
behavior (Borre et al., 2014; Sudo et al., 2004; Diaz Heijtz et al., 2011). Mice reared without
microbiota (‘‘germ-free’’) exhibit increased corticosterone response to restraint stress
and reduced expression levels of brain-derived neurotrophic factor in the hippocampus
(Sudo et al., 2004). The increased corticosterone response is partially reversedwith exposure
to Bifidobacterium longum subsp. infantis, a species dominating the human infant gut
(Sudo et al., 2004, Yatsunenko et al., 2012). Notably, colonization with B. infantis only
partly normalizes the corticosterone response in 6 week old mice, but not 14 week
old mice (Sudo et al., 2004). Slightly contrary to this research, germ-free mice showed
reduced anxiety behavior in light-dark and elevated maze plus tests (Diaz Heijtz et al.,
2011). However, the differences in the type of stressor (restraint stress vs. an open field)
may cause these contradictory stress responses in germ-free animals. Regardless, Diaz
Heijtz and colleagues also demonstrated only early life colonization of germ-free mice,
not colonization in mature mice, could normalize the behavior of germ-free mice (Diaz
Heijtz et al., 2011). These studies suggest critical neurodevelopmental windows exist in
early life during which gut microbiota are crucial to shaping behavior (Borre et al., 2014;
Allen-Blevins, Sela & Hinde, 2015).
Evolutionary context
If early life gut microbiota are critical for normal neurodevelopment, mothers necessarily
play an essential role in programming neurodevelopment through transmitting and
supporting the microbiota (Bäckhed et al., 2015; Allen-Blevins, Sela & Hinde, 2015;
Sela & Mills, 2010). Initial microbial colonization is vertically transmitted from
mother to offspring during delivery (Bäckhed et al., 2015; Dominguez-Bello et al., 2010;
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Mueller et al., 2014; Hinde & Lewis , 2015). The newly colonized infant gut is then exposed
to mother’s milk, which in humans contains glycans such as human milk oligosaccharides
(HMO) that are not digested by the infant (Marcobal & Sonnenburg, 2012; Sela & Mills,
2010). While the infant does not possess endogenous enzymes to cleave HMO, certain
species of gut microbiota can metabolize HMO, including B. infantis (Sela & Mills, 2010;
Sela et al., 2008; Sela et al., 2011; Sela et al., 2012). B. infantis is capable of metabolizing
HMO as a sole carbon source, and B. infantis, Bifidobacterium longum and Bifidobacterium
breve affect stress and anxiety behaviors (Yatsunenko et al., 2012; Sudo et al., 2004; Savignac
et al., 2014; Sela & Mills, 2010; Sela et al., 2008; Desbonnet et al., 2010). Particular strains
of Bifidobacterium can also produce γ -aminobutyric acid (GABA), a major inhibitory
neurotransmitter (Barrett et al., 2012; Yunes et al., in press). The resulting interactions
create a milk-microbiota-brain-behavior (M2B2) system, which may allow mothers to
influence infant behavior through their milk (Allen-Blevins, Sela & Hinde, 2015).
Experimental rationale
Studying the M2B2 system in model organisms presents unique challenges because
experimental techniques can induce stress in animals that affects microbiota and
behavior (Hoggatt et al., 2010; Bailey & Coe, 1999; Bailey, Lubach & Coe, 2004). Stress is
a challenge to homeostasis which may be caused by environmental, physiological, social, or
psychological stimuli (Bailey, 2014,Mendoza, in press). Early life stress, including neonatal
handling and maternal separation, can have long-term developmental consequences and
disrupt the regulation of crucial biopsychological pathways, such as the hypothalamus-
pituitary-adrenal axis (Dalmaz et al., 2015; O’Mahony et al., 2009). Gut microbiome
experiments frequently involve oral gavage of rodents with known bacterial strains, fecal
matter, or other compounds (Turnbaugh et al., 2006; Fujimura et al., 2014; Ji et al., 2012).
This technique induces stress responses and can be injurious or fatal to mice, particularly
when they are very young (Hoggatt et al., 2010; Flamm, 2012). Alterations in gut microbiota
in response to host stress have been demonstrated in mice and rhesus macaques (Tarr et
al., 2015; Bailey, Lubach & Coe, 2004; Bailey & Coe, 1999). If the gut microbiota is sensitive
to stress, invasive techniques, like gavage, introduce a potential confound. Changes in
microbial profiles over the course of an experiment could be due to the treatment or stress
induced from experimental techniques. Since the M2B2 system must be studied prior to
weaning, methods such as dosing water or chow with HMO are not effective. Therefore, a
non-invasive technique for administering prebiotic solutions directly to very young mice
is necessary.
The purpose of this experimentwas to determine a less stressfulmethod for administering
experimental prebiotic liquids to conventional mouse pups. Our aims were to develop a
method of studying particular diet-microbe interactions in non-gnotobioticmice. Reducing
psychological perturbation was a main goal because bifidobacteria that dominate the infant
gut microbiome are reduced after stress exposure (De Leoz et al., 2014; Bailey, Lubach &
Coe, 2004). Therefore, we predicted pups receiving a prebiotic solution in a more passive
manner would have higher amounts of Bifidobacteria. We tested two methods, active
and passive, of administering fructooligosaccharide (FOS), a previously demonstrated
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bifidogenic prebiotic (Howard et al., 1995), to mouse pups from post-natal day 1 to post-
natal day 21 (PND1-PND21). FOS was used in this pilot experiment due to its bifidogenic
properties and the prohibitive cost of HMO. Bifidobacterium and Bacteroides counts were
analyzed because of their potential roles in neurodevelopment (Allen-Blevins, Sela & Hinde,
2015; Hsiao et al., 2013; O’Sullivan et al., 2011), while Bacteroidetes and Firmicutes were
analyzed due to these phyla being dominant within human gut microbiomes.
MATERIALS & METHODS
Subjects
We conducted our methodological study (Fig. 1) in captive-bred laboratory mice (Mus
musculus). Six timed-pregnant C57BL/6J females and six C57BL/6J males were purchased
from The Jackson Laboratory (Bar Harbor, ME, USA) at six weeks old. Animals were
housed in the Harvard University Biological Research Infrastructure, a specific-pathogen
free facility, under standard Institutional Animal Care and Usage Committee (IACUC)
murine environmental conditions. Water and PicoLab commercial chow were available ad
libitum. In consideration of the greater risk of reduced maternal care and increased pup
mortality among C57BL/6J primiparae (Brown et al., 1999), initial litters were culled and
dams placed in single pair mating cages for one week. These mating pairs produced the
litters used for the experimentalmanipulations. One dammay have still been nulliparous, as
she exhibited signs of pregnancy but no litter was observed prior to being placed in amating
cage. However, the litter may have been delivered and cannibalized prior to observation.
This would be consistent with other first litters from these dams being cannibalized or
found dead. Due to the unexpected death of one male, M1 was mated to F1 and then to
F6. The other matings were as follows: M2–F2, M3–F4, M4–F3, and M5–F5. Animals were
maintained in breeding cages for seven days before females were removed to individual
cages for experimental manipulations. Males remained in single, separate home cages,
undisturbed except for cage changes, until euthanasia approximately one week after the
birth of their sired litter. All cages were clear plastic, 10.5 inches by 6.5 inches by 5.0 inches.
Experimental manipulations
Dams were randomly assigned to the following experimental groups: passive water, passive
fructooligosaccharide (FOS), active water, active FOS, buccal water, and buccal FOS. The
litters for each group were reduced to six on PND0, with the exception of the active water
litter, which only contained five pups at birth. The pregnancy of the buccal water dam
failed, leaving no experimental litter for the condition.
Pups in each experimental group were handled daily. At the beginning of each provision
of the assigned treatment, the home cage of the litter was placed next to a clean cage with
fresh bedding. The dam was removed from the home cage and placed into the clean cage
for the duration of pup manipulation for that day. Pups were immobilized by grasping
the skin at the nape and along the spine, and rotating their bodies to reveal the ventrum.
Starting at PND10, pups were lifted by the tails prior to grasping the nape. For active FOS
and water conditions, a micropipette tip was placed in the pup’s mouth and the dosage was
injected directly into the oral cavity. In passive conditions, a micropipette tip was used to
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Figure 1 Timeline for each treatment group. Samples were collected at time points post-natal day
(PND)0, PND7, PND14, and PND21.
transfer the dosage to a Crematocrit tube that was then placed near the pup’s mouth with
the intent to induce the suckling response (Szczypka et al., 1999). As pups in the passive
litters aged and the dosages increased (Fig. 2), only micropipette tips were used to place the
dosage near the pups’ mouths. The switch to only micropipette tips occurred on PND12
for the passive water group and PND15 for the passive FOS group. All tips and tubes were
autoclaved prior to use. For buccal conditions, the daily dosage was micropipetted onto a
sterile cotton swab, which was then inserted into the pup’s mouth. After receiving the daily
dosage, the pup was returned directly to the home cage and the next pup was removed
for dosing. Once pups began to open their eyes, they were placed into the clean cage with
the dam after dosing. When all pups had received their daily treatment, the dam and pups
were returned to the home cage.
FOS was purchased from Sigma-Aldrich Corp. and administered in a 2.5mM solution
for PND1-PND7and a 25mM solution for PND8-PND21. 25mM was the concentration
of HMO producing results when given to mice from birth to weaning in Kurakevich et al.
(2013). The 2.5mM dosage was used to determine whether the 25mM could be further
reduced, to decrease future HMO cost. Distilled, deionized water was used to create the
FOS solutions. Distilled, deionized water was also used for the water conditions.
Sample collection
Gastrointestinal tracts (GI) were collected from experimental groups on PND0, PND7,
PND14, and PND21, while control fecal samples from non-handled, non-dosed mice were
collected on PND14 and PND20. On PND0 as many pups as necessary to reduce litter
size to six were anesthetized with carbon dioxide, decapitated with sharp scissors, and
their GI tracts were collected. Since the active water litter had five pups at birth, only one
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Figure 2 Daily dosage of FOS or water in microliters.Dosage of water or FOS increased from 2 micro-
liters (µL) to 12 microliters (µL) over the course of the experiment.
pup was euthanized on PND0. On PND7, one pup from each litter was euthanized in
the same manner and their GI tract collected. At PND14, one pup from each litter was
euthanized with carbon dioxide and their GI tract collected. On PND21, all remaining
pups in the litter were euthanized with carbon dioxide and their GI tracts collected. Dams
were also euthanized with carbon dioxide on PND21 and GI tracts were collected. Sires
were euthanized with carbon dioxide and GI tracts were collected approximately one week
after the birth of their litter. GI tracts were snap-frozen in dry ice and stored at −80 ◦C
until analysis. Voided fecal pellet samples were also collected on PND14 and PND20 from
non-handled C57BL/6J pups and two non-handled dams housed in the same facility,
matched for living conditions and diet, which served as controls to the treatment groups.
Animal use was approved by the Harvard University Institutional Animal Care and Use
Committee under protocol 14-08-217.
qRT-PCR analysis
Fecal pellet and GI tract material was transferred from Harvard University, Cambridge,
Massachusetts on dry ice to University of Massachusetts-Amherst, Amherst, Massachusetts
for quantitative real-time polymerase chain reaction (qRT-PCR) analysis. GI tracts were
thawed on ice and fecal material from the tracts was scraped into sterile sample tubes.
Samples were unattainable from PND0 GI tracts (N = 9), due to lack of fecal matter within
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the tracts. Additionally, samples from the buccal FOS group (F6,N = 10) were not analyzed
because there was no litter from F3 (the buccal water dam).
DNA was extracted using a bead beating protocol (FastPrep-24TM 5G MP Biomedicals
Inc, US) and standard protocol for the QIAmp DNA stool kit (Qiagen, Valencia, CA, US).
DNA quality was determined via nanodrop (Thermo Fisher Scientific, Waltham, MA,
US) and extracted DNA was diluted to 4 ng/µL. Custom TaqMan gene expression assays
(Thermo Fisher Scientific) for Bifidobacterium, Firmicutes, Bacteroides, and Bacteroidetes
were designed using the following sequences:
Bifidobacterium (Penders et al., 2005):
Forward primer: GCGTGCTTAACACATGCAAGTC
Reverse primer: CACCCGTTTCCAGGAGCTATT
Probe: TCACGCATTACTCACCCGTTCGCC
Firmicutes (Lecerf et al., 2012):
Forward primer: GAATCTTCCACAATGGAC-
GAAAG
Reverse primer: AATACCGTCAATACCTGAACAGT-
TACTC
Probe: CTGATGGAGCAACGCCGCGT
Bacteroides (Layton et al., 2006):
Forward primer: GAGAGGAAGGTCCCCCAC
Reverse primer: CGCTACTTGGCTGGTTCAG
Probe: CCATTGACCAATATTCCTCACTGCTGCCT
Bacteroidetes (Dick & Field, 2004):
Forward primer: AACGCTAGCTACAGGCTTAACA
Reverse primer: ACGCTACTTGGCTGGTTCA
Probe: CAATATTCCTCACTGCTGCCTCCCGTA
Samples were run in triplicate, with negative control blanks of RNAse free water and
a standard curve included on each 96-well plate, using Applied Biosystems 7500 Fast
Real-Time PCR system (Thermo Fisher Scientific). Wells included 1 µL of TaqMan gene
expression assay, 10 µL of TaqMan master mix (Thermo Fisher Scientific), 5 µL of RNAse
free water, and 4 µL of the DNA sample for a total of 20 µL in each well. Plates were run
at 50C for 2 min, 95C for 10 min, and then 45 cycles of 95C for 15 s and 60C for 1 min.
Statistical analysis
TheKruskal-Wallis test was performed inRStudio (Version 0.98.1103) to compare variation
in Bifidobacterium, Firmicutes, Bacteroides, and Bacteroidetes quantity between treatment
groups: active fructooligosaccharide (FOS), passive FOS, active water, and passive water.
Wilcoxon rank sum tests were performed in RStudio (Version 0.98.1103) to compare
variation in Bifidobacterium, Bacteroides, and Bacteroidetes quantity in the combined
totality of the treatment groups (active FOS, passive FOS, active water, and passive water)
versus the fecal pellet samples from non-handled mice housed in the same facility, for
both pup and dam samples. Since the sample sizes were very unequal for non-handled
control (N = 7) versus treatment (N = 21) pups, Wilcoxon tests were also performed to
compare the quantity of Bifidobacterium, Bacteroides, and Bacteroidetes in the combined
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Figure 3 log10 Colony-forming unit (CFU) equivalents/ng of sample DNA for control and treatment
groups.Wilcoxon rank sum test demonstrated significant differences between the control and treatment
samples for all Bifidobacterium (p < 0.001), Bacteroides (p < 0.001), and Bacteroidetes (p-value=
0.008).There was also a significant difference for Firmicutes between the WP and FA groups (p-value=
0.009). W-P, water passive, W-A, water active; F-A, FOS active; F-P, FOS passive.
treatment groups against the fecal pellet samples from pups on PND14 and PND21. For
PND14, sample sizes were equal at four control and four treatment pups. As no fecal pellet
samples were collected on PND21 and no GI tracts were collected on PND20, the fecal
pellet samples from PND20 were compared to GI tract samples from PND21. Significance
for the Kruskal-Wallis and Wilcoxon tests was established as p< 0.05. One sample, the
FOS passive PND7, was excluded from analysis due to bacterial detection levels below the
standard curve.
RESULTS
Gastrointestinal (GI) tract samples
A log10 colony-forming unit (CFU) equivalents/ng of DNA were measured for
Bifidobacterium, Bacteroides, Bacteroidetes, and Firmicutes for each pup treatment group
(N = 21, Fig. 3). All treatment group samples demonstrated some amount of Bacteroidetes,
Bacteroides, and Firmicutes. Maximum, minimum, and median counts, as well as the
interquartile range, for each taxa are listed in Table 1. One data point was excluded from
the Bifidobacterium counts due to a lack of agreement among triplicate samples (active
water, PND7). From a total of 20 treatment samples, qRT-PCR revealed the majority (19)
to have<101 quantity of bifidobacteria. The Kruskal-Wallis test determined no significant
difference in the median bacterial counts across treatment groups for Bacteroidetes
(p= 0.546), Bacteroides (p= 0.534), or Bifidobacterium (p= 0.786). However, there was a
significant difference for Firmicutes (p= 0.043).
To determine which treatment groups were significantly different in the amount of
Firmicutes, Wilcoxon rank sum tests were performed in a pairwise fashion. There were
no significant differences in Firmicutes amounts between the passive water and active
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Table 1 log 10 Colony-forming unit (CFU) equivalents/ng of sample DNA for pup samples.Maximum,
minimum, median, and interquartile range (IQR)counts for Bacteroidetes, Bacteroides, Bifidobacterium,
and Firmicutes in treatment (GI tract, N = 21) and control (Fecal pellets, N = 7) pups.
Group/Taxa Maximum Minimum Median Interquartile
range
GI Tract—Pups (N = 21)
Bacteroidetes 104 <101 103 101
Bacteroides 104 <101 104 101
Bifidobacterium 101 <101 <101 <101
Firmicutes 105 101 104 <101
Fecal Pellets—Pups (N = 7)
Bacteroidetes 104 103 103 <101
Bacteroides 104 104 104 <101
Bifidobacterium 103 <101 102 <101
Firmicutes 106 106 106 <101
water groups (p= 0.171), passive water and passive FOS groups (p= 0.247), active water
and active FOS groups (p= 0.067), or active FOS and passive FOS groups (p= 0.329).
However, there was a significant difference between the median Firmicutes counts for the
passive water (103) and active FOS groups (104; p= 0.009).
Bacterial counts were also quantified for samples from the GI tracts of the litter sires
(N = 4, Fig. 4) and the dams of each treatment group and the buccal water dam with no
litter (N = 5, Fig. 5). Maximum,minimum andmedian counts, along with the interquartile
range, are in Table 2. The maximum Bifidobacterium count for the sires came from the sire
mated to the buccal water dam, which produced no litter. All samples for the treatment
dams contained <101 Bifidobacterium.
Fecal pellet samples
Fecal pellet samples from non-handled pups and dams were measured for Bifidobacterium,
Bacteroides, Bacteroidetes, and Firmicutes log10 CFU equivalents/ng of DNA as a control
(Fig. 3 for pups, Fig. 5 for dams). Maximum, minimum, and median counts, with the
interquartile ranges, can be found in Table 1 for the pups, while the same counts for the
dams can be found in Table 2. The maximum Bifidobacterium count of 103 was found in
two pup samples. For the dams, both samples contained 101 Bifidobacterium.
Gastrointestinal tract (GI) versus fecal pellet samples
Since there were no significant differences in bacterial counts of Bacteroidetes, Bacteroides,
or Bifidobacterium across treatment groups, we combined these groups for analysis against
the fecal pellet controls. The Wilcoxon rank sum test revealed significant differences
between counts for all bacterial taxa (Bifidobacterium p value < 0.001, Bacteroidetes p value
= 0.008, Bacteroides p value < 0.001) in the treatment groups and bacterial counts for the
fecal pellets collected from pups (Fig. 3).
Comparisons by post-natal day also revealed significant differences between non-
handled and handled pups. Wilcoxon rank sum tests demonstrated significant differences
in the medians of the control and treatment samples for Bacteroides (control median: 104
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Figure 4 log10 colony-forming unit (CFU) equivalents/ng of sample DNA for feces collected from the
GI tracts of treatment litter sires. Samples from water sires contained Bifidobacteria, while samples from
FOS sires did not.
Figure 5 The log10 colony-forming units (CFU) equivalents/ng of sample DNA for control and experi-
mental dams. There was no significant difference between the samples, despite the treatment dams having
no bifidobacteria. The F3 dam was the buccal water dam that did not deliver a litter. W-P, passive water;
W-A, active water; F-A, active FOS; F-P, passive FOS.
(IQR = <101), treatment median: 103 (IQR = 102), p-value = 0.03) and Bifidobacterium
(control median: 102 (IQR = <101), treatment median: < 101 (IQR =< 101), p-value
= 0.03) on PND14, but a non-significant difference for Bacteroidetes (p-value = 0.057,
Fig. 6). These significant differences for Bacteroides (p-value =0.003) and Bifidobacterium
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Table 2 The log 10 colony-forming unit (CFU) equivalents/ng of sample DNA for dams and sires.
Maximum, minimum, median and interquartile range (IQR) counts for Bacteroidetes, Bacteroides, Bifi-
dobacterium, and Firmicutes in sires, and treatment and control dams.
Group/Taxa Maximum Minimum Median Interquartile
range
GI Tract—Dams (N = 5)
Bacteroidetes 104 103 103 <101
Bacteroides 104 104 104 <101
Bifidobacterium <101 <101 <101 <101
Firmicutes 105 104 104 <101
GI Tract—Sires (N = 4)
Bacteroidetes 104 103 103 <101
Bacteroides 104 103 104 <101
Bifidobacterium 103 <101 101 102
Firmicutes 104 103 104 <101
Fecal Pellets—Dams (N = 2)
Bacteroidetes 103 103 103 <101
Bacteroides 104 104 104 <101
Bifidobacterium 101 101 101 <101
Firmicutes 106 106 106 <101
(p-value = 0.006) median counts in the control and treatment samples were also evident
at PND21, despite a large difference in sample size (control N = 3, treatment N = 14).
Wilcoxon rank sum tests found no significant difference between samples from the two
control dams and samples from the treatment dams (N = 4). This lack of significance was
maintained when the F3 dam, who had no litter and received no treatment, was included
(Fig. 5).
DISCUSSION
In this experiment, we specifically focused on Bifidobacterium, Firmicutes, Bacteroides,
and Bacteroidetes, phyla frequently studied in animal models due to their presence
and hypothesized importance in the human gut. While quantifying and studying
the gut microbiota as a whole is a necessary step to fully understand interactions
between the host and microbiota, we narrowed our focus to these phyla because of
our particular aims for this study. Bifidobacterium and Bacteroides are both good candidate
genera for containing species that potentially affect neurodevelopment during infancy.
Both genera have previously been shown to contain species, such as Bifidobacterium
longum subsp. infantis and Bacteroides fragilis, that can affect behavior, possibly through
neurodevelopmental pathways (Allen-Blevins, Sela & Hinde, 2015; Sudo et al., 2004; Hsiao
et al., 2013). Firmicutes and Bacteroidetes were also quantified due to their correlation
with obesity, inverse correlation with each other, and frequent measurement in gavage
experiments (Turnbaugh et al., 2006; Li et al., 2015).
Themajor finding of this paper is the significant decrease in Bifidobacterium, Bacteroides,
and Bacteroidetes present in the gut microbiota of handled animals provided either water
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Figure 6 The log10 colony-forming unit (CFU) equivalents/ng of sample DNA from control and treat-
ment samples collected on post-natal day 14. The median Bifidobacterium and Bacteroides counts in the
control samples were significantly different from the treatment samples (p-value= 0.03 for both compar-
isons) as tested by Wilcoxon rank sum test. The medians of Bacteroidetes counts were not significantly
different between the treatment and control groups (p-value= 0.057). Firmicutes could be compared be-
tween control and treatment groups, because there were significant differences between treatment groups
for this taxa. W-P, passive water; W-A, active water; F-A, active FOS; F-P, passive FOS.
or FOS. Cognizant of stress effects on bifidobacteria (Bailey, Lubach & Coe, 2004), our
experiment was designed to determine a less-invasive technique to administer bifidogenic
compounds to neonatal mice. While the ultimate goal was to create a method for
administration of humanmilk oligosaccharides (HMO) tomice, FOSwas used in this initial
experiment due to the prohibitive cost ofHMO.We expected to find themost bifidobacteria
in the group passively fed FOS, since this was expected to be the least stressful technique and
included supplementation of a compound previously demonstrated as bifidogenic (Howard
et al., 1995). However, there were no significant differences in Bacteroidetes, Bacteroides,
or Bifidobacterium across our treatment groups, falsifying our prediction. There was a
significant difference between the median amount of Firmicutes in the pups provided
water passively and the pups actively provided with FOS. These two treatment groups were
different on both factors (treatment method and substance), so the significant difference
is not suprising. Additionally, administration of FOS is correlated with an increase in
Firmicutes (Li et al., 2015). The median amounts of Firmicutes across treatment groups
remained between 103 and 104, while the control pups had a median amount of 106. While
we were unable to statistically compare these values due to the difference in treatment
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groups for Firmicutes, there seems to be a substantial difference between the amount of
Firmicutes in the control and treatment groups. The statistically significant differences
in quantities of Bacteroides, Bacteroides, and Bifidobacterium between the control and
treatment groups suggest a factor common to all four treatment groups may have affected
these phyla of gut microbiota.
Lack of initial exposure toBifidobacterium, Bacteroides, and Bacteroidetes and differences
between voided fecal pellets and GI tract fecal samples may explain the differences in
bacterial quantities between our handled and non-handled animals; however, we think
these are unlikely explanations. The absence of bifidobacteria in the handled dams creates
the possibility of the handled pups lacking bifidobacteria because they had no exposure.
However, the counts of Bifidobacterium in the water sires indicate at least the dams for
the water groups were exposed to bifidobacteria for seven days. Sires were cohoused with
the dams for one week and the coprophagic habit of mice (Heinrichs, 2001) makes dam
exposure to bifidobacteria highly likely. While both the FOS sires and dams appear to
be lacking bifidobacteria, one of the FOS pups had the highest count of bifidobacteria
in the treatment groups (>101). Therefore, non-exposure to bifidobacteria is unlikely to
explain our results. Non-exposure also cannot explain the differences in Bacteroides and
Bacteroidetes, as all of the treated dams contained these taxa. Additionally, the differences
in the use of voided fecal pellet samples from the control animals (collected from cages)
and internal fecal samples from the treatment animals (collected from the distal colon of
GI tracts) are also unlikely to explain the magnitude of difference in bifidobacteria. Fecal
samples in both mice and humans have demonstrated much higher bifidobacterial counts
than gut lumen samples (Marcotte & Lavoie, 1996; Ouwehand et al., 2004). However, our
treatment samples were of intact feces collected from the distal colon and not samples of
the mucosa or luminal fluid. Also, the two water sires had counts of Bifidobacterium in
stool from their intestinal tract that were greater than the counts in the voided fecal pellets
of the control dams. Therefore, while some variation may be expected due to differences in
sample collection, it is unlikely to reach the magnitude of difference between the median
bifidobacteria from the control pups and the treatment pups.
While non-exposure to bacteria is an unlikely explanation, the stress of handling,
common to all treatment groups, may have contributed to the changes across the treatment
group gut microbiota. Bifidobacterium, known to be susceptible to host stress (Bailey,
Lubach & Coe, 2004), was decreased to the point of >101 in the majority of our treated
mice, the largest decrease of any of the bacterial taxa in our study. Since all of the control
animals and two of our minimally handled sires largely maintained Bifidobacterium in
their gut, and all animals were of the same genetic background, in the same facility on
the same diet, the sharp decrease in this taxa, known to be stress-sensitive, is likely due
to a stressor. It should be noted that this explanation may not be valid for the lack of
Bifidobacterium in the FOS sires. Additionally, Lactobacillus, a genus within the Firmicutes
phylum is also stress-sensitive (Bailey, 2014). While the significant difference in Firmicutes
between the passive water pups and active FOS pups suggests administration of FOS was
able to increase the amount of Firmicutes, all of the treatment groups still had a median
amount 102–103 below the median amount of the control group. Therefore, handling stress
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could potentially be driving decreases in the other bacterial taxa as well, to varying degrees.
Both passive and active handling techniques appear to negatively influence the amount of
Bifidobacterium, Bacteroides , and Bacteroidetes in the guts of our treated subjects, with the
quantity of Bifidobacterium being the most severely affected.
If even non-invasive handling stress is potentially correlated with significant changes
to the gut microbiota and the loss of an entire taxon, this creates a particular challenge
for research centered on the gut microbiota and early life development. To adequately
study a potential milk-microbiota-brain-behavior (M2B2) pathway, supplementation of
animal models with HMO may be necessary (Allen-Blevins, Sela & Hinde, 2015). While
gavage is frequently used to administer compounds to rodents, this technique can stress the
animal (Flamm, 2012; Hoggatt et al., 2010). Stress in early life, such as maternal separation,
is correlated with significant changes gut microbiota (Bailey & Coe, 1999; O’Mahony et
al., 2009). If non-invasive handling is provoking a stress response in laboratory animals
significant enough to affect gutmicrobiota, then handling young animals duringmicrobiota
experiments may confound the results. For example, handling all of the animals, including
controls and those receiving vehicles, may lead a researcher to conclude there are none or
reduced levels of a bacterium that may actually be diminished due to handling stress. Such
a reduction in bacterial taxa may mask potential interactions between an experimental
compound and bacterial taxa that might be present if the compound was administered
without stress.More research is necessary to determine if common experimental techniques
are creating confounds in murine microbial studies.
Synbiotics, a combination of prebiotics and the bacteria of interest (Schrezenmeir &
De Vrese, 2001), and communal use of non-handled control animals may mitigate the
potential challenges of handling stress affecting gut microbiota. Since synbiotics provide
both the substrate for bacterial growth and the bacteria (Schrezenmeir & De Vrese, 2001),
they may provide a method for studying the most stress sensitive bacteria. For both human
and animal studies, exposing the subject to the desired bacteria daily may continually
replace the diminished strains and mimic the effects of permanent colonization for the
duration of exposure. Microbial and other changes can then be compared in these animals
to non-handled control animals. As a guiding principle of the American Association for
Laboratory Animal Science (Committee for the Update of the Guide for the Care and Use of
Laboratory Animals, 2011) is understandably to reduce the number of animals used in
experiments, there may be a reluctance to include negative control animals that are not
handled at all. The reduction principle can still be achieved for gut microbiota studies if
multiple labs share feces and potentially other data from non-handled animals housed in
the same facilities, on the same diets, and from the same genetic backgrounds.
Our study has several caveats and limitations. It is important to note the small sample
sizes in our study. The small number of control samples compared to the treatment
samples may have impacted our results. To determine if handling is truly causing such a
large difference in gut microbiota, replicating this study with a greater number of control
samples would be of great value. We also did not take corticosterone measurements of
the mice, which would have allowed us to quantify their physiological stress reaction to
handling. Additionally, the stress of handling does not explain the lack of bifidobacteria in
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the FOS sires or the buccal water dam. Since this dam had no litter, she was also minimally
handled. However, these animals contained counts of Bacteroidetes, Bacteroides, and
Firmicutes on par with their sex and age-matched conspecifics. After removal from mating
cages, all dams were housed separately until parturition. While isolation of pregnant
females to prevent cannibalism of pups is an accepted practice (Committee for the Update
of the Guide for the Care and Use of Laboratory Animals, 2011), since this female never had
a litter, the social stress of isolation may have affected her differently. The FOS sires may
have lacked bifidobacteria due to an unnoticed illness or a difference in genotype (Bevins &
Salzman, 2011; Wacklin et al., 2011), but this is simply speculation. Therefore, since these
two animals present a conundrum and it is highly important to determine the extent of
handling effects on gut microbiota, this research should be repeated with larger sample
sizes and including measures of corticosterone. Prior to that, researchers should remain
cognizant of potential handling effects on their data.
Additionally, we used quantitative real-time PCR (qRT-PCR) to quantify the bacteria
number in our samples, which is regarded as a sensitive and specific method to detect
commensal bacteria (Castillo et al., 2006). Though qRT-PCR is regarded as an accurate
method, we found some samples to contain more Bacteroides than Bacteroidetes which
might be due to qRT-PCR amplification bias. Thus, primers should be carefully designed
to ensure the same amplification efficiency among the bacteria of interest in future studies.
CONCLUSION
Although more research is clearly necessary, the stress of handling, or even the social stress
of isolation, may have the capacity to affect murine gut microbiota. Particularly when using
young animals to investigate microbial responses to prebiotics, such as studies focusing
on the potential milk-microbiota-brain-behavior (M2B2) system, care should be taken
during experiments to ensure necessary controls and accurate data collection. Sharing fecal
samples from control animals of the same genetic background, housed in the same facility,
and fed the same diet would met standards of animal reduction, while enabling comparison
of handled treatment animals to non-handled animals.
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